S.B. 2586 Summary

• Permits qualifying patients to be reimbursed by health insurers, mutual benefit societies, and health maintenance organizations for medical cannabis and manufactured cannabis products purchased under Hawaii law.

• Establishes dollar-for-dollar reimbursement for qualifying patient spending between specified monthly amounts, with specific monthly maximums and yearly reimbursement caps (specific dollar amounts left blank in bill text).

• Requires insurers, mutual benefit societies, and health maintenance organizations to establish reimbursement systems that process claims on at least a quarterly basis.

• Mandates the auditor to conduct an impact assessment report evaluating the social and financial impacts of these insurance mandates and submit findings to the legislature no later than twenty days before the 2021 regular session.

• Takes effect July 1, 2050.